http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-510251-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d595ec481a2a081fed4aa2fd4ff52d8 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
| filingDate | 2001-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2a23627393506098735bc28f10fd056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e80c0885c636e6e1b32abc57c52aab52 |
| publicationDate | 2001-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NZ-510251-A |
| titleOfInvention | Lanthionine antibiotic compositions isolated from Streptococcus mutans |
| abstract | Certain bacteria indigenous to humans produce antimicrobial substances called bacteriocins that inhibit other bacteria, including members of their own species. Mutacins are a class of antibiotic substances made by Streptococcus mutans. Disclosed is the purification and biochemical characterization of a lanthionine-containing mutacin peptide from S. mutans, and a pharmaceutical composition containing it. The purified peptide is pH- and temperature-stable and its amino acid composition indicates the presence of lanthionine and beta -methyllanthionine. Also provided are methods of making and using the purified polypeptide. |
| priorityDate | 1996-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 325.